MicroRNA155 in non-small cell lung cancer: a potential therapeutic target
Lung cancer (LC) is the second most commonly diagnosed cancer among both men and women, and it stands as the leading cause of cancer-related mortality, characterized by high rates of morbidity and mortality. Among its subtypes, non-small cell lung cancer (NSCLC) is the most prevalent and one of the...
Príomhchruthaitheoirí: | Xiangju Wei, Xianmin Xiong, Ze Chen, Bi Chen, Cantang Zhang, Wenhui Zhang |
---|---|
Formáid: | Alt |
Teanga: | English |
Foilsithe / Cruthaithe: |
Frontiers Media S.A.
2025-02-01
|
Sraith: | Frontiers in Oncology |
Ábhair: | |
Rochtain ar líne: | https://www.frontiersin.org/articles/10.3389/fonc.2025.1517995/full |
Míreanna comhchosúla
Míreanna comhchosúla
-
MicroRNA-155 targets SOCS1 to inhibit osteoclast differentiation during orthodontic tooth movement
de réir: Yao Jiao, et al.
Foilsithe / Cruthaithe: (2023-12-01) -
MicroRNA-155 Promotes Atherosclerosis Inflammation via Targeting SOCS1
de réir: Yang Yang, et al.
Foilsithe / Cruthaithe: (2015-07-01) -
Expression levels of microRNAs are not associated with their regulatory activities
de réir: Wu Jiarui, et al.
Foilsithe / Cruthaithe: (2011-09-01) -
MicroRNA-155 Implication in M1 Polarization and the Impact in Inflammatory Diseases
de réir: Sergiu Pasca, et al.
Foilsithe / Cruthaithe: (2020-04-01) -
Inhibition of microRNA-155 Reduces Neuropathic Pain During Chemotherapeutic Bortezomib via Engagement of Neuroinflammation
de réir: Zongsheng Duan, et al.
Foilsithe / Cruthaithe: (2020-03-01)